Download PDF
CC BY-NC-ND 4.0 · Arch Plast Surg 2022; 49(03): 339-345
DOI: 10.1055/s-0042-1744419
Breast/Trunk
Original Article

Prolonged Opioid Use Among Opioid-Naive Women Undergoing Breast Reconstructive Surgery

Ankhita R. Samuel 
1   Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia
,
Laura Fuhr
1   Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia
,
Brent R. DeGeorge Jr
1   Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia
,
Jonathan Black
1   Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia
,
Christopher Campbell
1   Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia
,
John T. Stranix
1   Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Background Patients that undergo mastectomy for breast cancer with reconstruction may be prone to prolonged opioid use. As risk factors are not well-established, this article sought to better understand the risk factors that may be associated with this.

Methods Patients that underwent breast reconstruction between 2010 and 2018 were identified in PearlDiver, a national insurance claims database. Patient demographics and comorbidities were elucidated, and various complications were then identified. Descriptive statistics as well as a multivariate analysis was used to evaluate the association of risk factors and complications.

Results Breast reconstruction patients of 24,765 were identified from this database. Obesity, tobacco use, benzodiazepine use, and anticonvulsant use were all associated with prolonged opioid prescriptions greater than 90 days after both alloplastic and autologous reconstruction.

Conclusion Prolonged opioid use continues to remain a topic of concern, and particularly in cancer patients that undergo breast reconstruction. Providers should be aware of potential risk factors for this to reduce this chance following breast reconstruction surgery.

Keywords

prolonged opioid use - breast reconstruction - risk factors

Author Contributions

Conceptualization: A.R.S. and J.T.S. Data curation: A.R.S., J.T.S. Formal analysis: A.R.S., J.T.S. Methodology: J.T.S. Project administration: A.R.S. Visualization: A.R.S. and J.T.S. Writing - original draft: A.R.S. and L.F. Writing - review and editing: L.F., B.R.D.Jr, J.B., C.C., J.S.


Supplementary Material



Publication History

Article published online:
27 May 2022

© 2022. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Centers for Disease Control and Prevention (CDC). Understanding the epidemic [Internet]. Atlanta, GA: CDC; c2020. Accessed March 19, 2021 at: https://www.cdc.gov/drugoverdose/epidemic/index.html
    Google Scholar
  • 2 Roth RS, Qi J, Hamill JB. et al. Is chronic postsurgical pain surgery-induced? A study of persistent postoperative pain following breast reconstruction. Breast 2018; 37: 119-125
    CrossrefPubMedGoogle Scholar
  • 3 McGugin CJ, Coopey SB, Smith BL. et al. Enhanced recovery minimizes opioid use and hospital stay for patients undergoing mastectomy with reconstruction. Ann Surg Oncol 2019; 26 (11) 3464-3471
    CrossrefPubMedGoogle Scholar
  • 4 Woeste MR, Bhutiani N, Geller AE, Eldridge-Hindy H, McMasters KM, Ajkay N. Identifying factors predicting prolonged opioid use after mastectomy. Ann Surg Oncol 2020; 27 (04) 993-1001
    CrossrefPubMedGoogle Scholar
  • 5 Marcusa DP, Mann RA, Cron DC. et al. Prescription opioid use among opioid-naïve women undergoing immediate breast reconstruction. Plast Reconstr Surg 2017; 140 (06) 1081-1090
    CrossrefPubMedGoogle Scholar
  • 6 Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg 2017; 125 (05) 1733-1740
    CrossrefPubMedGoogle Scholar
  • 7 Azad AD, Bozkurt S, Wheeler AJ, Curtin C, Wagner TH, Hernandez-Boussard T. Acute pain after breast surgery and reconstruction: a two-institution study of surgical factors influencing short-term pain outcomes. J Surg Oncol 2020; 122: 623-631
    CrossrefPubMedGoogle Scholar
  • 8 Chao LF, Patel KM, Chen SC. et al. Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation. Breast Cancer Res Treat 2014; 146 (02) 299-308
    CrossrefPubMedGoogle Scholar
  • 9 Falk Dahl CA, Reinertsen KV, Nesvold IL, Fosså SD, Dahl AA. A study of body image in long-term breast cancer survivors. Cancer 2010; 116 (15) 3549-3557
    CrossrefPubMedGoogle Scholar
  • 10 Leroux TS, Saltzman BM, Sumner SA. et al. Elective shoulder surgery in the opioid naïve: rates of and risk factors for long-term postoperative opioid use. Am J Sports Med 2019; 47 (05) 1051-1056
    CrossrefPubMedGoogle Scholar
  • 11 Nayyar A, Strassle PD, Reddy KG. et al. Variations in the utilization of immediate post-mastectomy breast reconstruction. Am J Surg 2019; 218 (04) 712-715
    CrossrefPubMedGoogle Scholar
  • 12 Dwyer MK, Tumpowsky CM, Hiltz NL, Lee J, Healy WL, Bedair HS. Characterization of post-operative opioid use following total joint arthroplasty. J Arthroplasty 2018; 33 (03) 668-672
    CrossrefPubMedGoogle Scholar
  • 13 Murphy BL, Hanson KT, Hieken TJ, McLaughlin S, Gray RJ, Habermann EB. Patient-reported experience after outpatient breast surgery. Am J Surg 2019; 218 (01) 175-180
    CrossrefPubMedGoogle Scholar
  • 14 Shen C, Thornton JD, Gu D. et al. Prolonged opioid use after surgery for early-stage breast cancer. Oncologist 2020; 25 (10) e1574-e1582
    CrossrefPubMedGoogle Scholar
  • 15 Kendall MC, Castro Alves LJ. Prescription opioid use among opioid-naïve women undergoing immediate breast reconstruction. Plast Reconstr Surg 2018; 142 (04) 609e
    CrossrefPubMedGoogle Scholar
  • 16 Yoon AP, Qi J, Brown DL. et al. Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast 2018; 37: 72-79
    CrossrefPubMedGoogle Scholar
  • 17 Gassman AA, Yoon AP, Maxhimer JB. et al. Comparison of postoperative pain control in autologous abdominal free flap versus implant-based breast reconstructions. Plast Reconstr Surg 2015; 135 (02) 356-367
    CrossrefPubMedGoogle Scholar
  • 18 Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain 2015; 156 (12) 2413-2422
    CrossrefPubMedGoogle Scholar
  • 19 Fassoulaki A, Melemeni A, Staikou C, Triga A, Sarantopoulos C. Acute postoperative pain predicts chronic pain and long-term analgesic requirements after breast surgery for cancer. Acta Anaesthesiol Belg 2008; 59 (04) 241-248
    PubMedGoogle Scholar
  • 20 Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths: United States, 2010–2015. Morb Mortal Wkly Rep 2016; 65 (50-51): 1445-1452
    CrossrefPubMedGoogle Scholar
  • 21 Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 2011; 26 (12) 1450-1457
    CrossrefPubMedGoogle Scholar
  • 22 Johnson SP, Chung KC, Zhong L. et al. Risk of prolonged opioid use among opioid-naïve patients following common hand surgery procedures. J Hand Surg Am 2016; 41 (10) 947-957
    CrossrefPubMedGoogle Scholar
  • 23 Stark N, Kerr S, Stevens J. Prevalence and predictors of persistent post-surgical opioid use: a prospective observational cohort study. Anaesth Intensive Care 2017; 45 (06) 700-706
    CrossrefPubMedGoogle Scholar
  • 24 Fahy AS, Jakub JW, Dy BM. et al. Paravertebral blocks in patients undergoing mastectomy with or without immediate reconstruction provides improved pain control and decreased postoperative nausea and vomiting. Ann Surg Oncol 2014; 21 (10) 3284-3289
    CrossrefPubMedGoogle Scholar
  • 25 Bourazani M, Papageorgiou E, Zarkadas G. et al. The role of muscle relaxants: spasmolytic (thiocochlicoside) in postoperative pain management after mastectomy and breast reconstruction. Asian Pac J Cancer Prev 2019; 20 (03) 743-749
    CrossrefPubMedGoogle Scholar
  • 26 Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin 2018; 68 (03) 182-196
    CrossrefPubMedGoogle Scholar
  • 27 Kulkarni AR, Pusic AL, Hamill JB. et al. Factors Associated with acute postoperative pain following breast reconstruction. JPRAS Open 2017; 11: 1-13
    CrossrefPubMedGoogle Scholar
  • 28 Campbell C. “Opioids in Plastic Surgery.” Lecture, Chicago, Illinois, September 29th, 2018